MedPath

Multicenter clinical trial: treatment effect of lansoprazole on non-traumatic osteonecrosis of the femoral head

Phase 2
Conditions
idiopathic osteonecrosis of the femoral head
Registration Number
JPRN-UMIN000032412
Lead Sponsor
Sapporo Medical University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with pain suggesting femoral head collapse (Stage III). 2. Patients underwent hip surgery. 3.Patients with alcohol-abuse or dementia 4. Past allergy to lansoprazole. 5. Patients treatment with atazanavir sulfate (Reyataz).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath